A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

NCT05864846 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberous Sclerosis Complex Associated Neuropsychiatric Disease

Interventions

DRUG: Cannabidiol Oral Solution [Epidiolex]

Sponsor

Jazz Pharmaceuticals